Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan

Bone Marrow Transplantation
M YanadaS Kato

Abstract

Despite recent advances, graft-versus-host disease (GVHD) remains the main cause of treatment failure for patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Tacrolimus (FK506) has been increasingly used in place of cyclosporine (CSP), and several studies have shown that FK506 reduces the incidence of acute GVHD more effectively than does CSP. However, no survival benefits have been demonstrated, and no established consensus exists on the choice of these immunosuppressive agents. To compare a CSP-based and an FK506-based regimen, we performed a large-scale retrospective study by using the data of 1935 patients who underwent HSCT from HLA-identical sibling donors (SIB-HSCT) and 777 patients who underwent HSCT from unrelated donors (UD-HSCT). For patients undergoing UD-HSCT, FK506 significantly reduced the risk of acute GVHD and treatment-related mortality (TRM) without an increase in relapse, thus improving overall survival (OS) (hazard ratio (HR): 2.20, 95% confidence interval (CI): 1.60-3.04, P<0.0001 for grade II-IV acute GVHD; HR: 1.81, 95% CI: 1.32-2.48, P=0.0003 for TRM; HR: 1.62, 95% CI: 1.23-2.14, P=0.0007 for OS). This superiority of FK506 was not observed in SIB-HSCT cases. These findings ind...Continue Reading

References

Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
Jul 7, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M M HorowitzJ R Wingard
Aug 18, 2001·Bone Marrow Transplantation·A HiraokaUNKNOWN Japanese FK506 BMT(Bone Marrow Transplantation) Study Group

❮ Previous
Next ❯

Citations

Nov 11, 2008·Bone Marrow Transplantation·R RamO Shpilberg
Feb 8, 2006·Current Opinion in Oncology·Javier Bolaños-Meade
Oct 6, 2012·Biological & Pharmaceutical Bulletin·Noriyasu FukuokaHitoshi Houchi
Jun 24, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kara Fortune, Daniel Couriel
Apr 24, 2007·Best Practice & Research. Clinical Haematology·Ernst Holler
May 18, 2016·International Journal of Hematologic Oncology·Erin Gatza, Sung Won Choi
Jun 3, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yoshihiro InamotoPaul J Martin
Mar 16, 2007·British Journal of Haematology·Edward S Morris, Geoffrey R Hill
Jun 21, 2007·Transplant International : Official Journal of the European Society for Organ Transplantation·Yoshinobu AisaShinichiro Okamoto
Oct 28, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rainer StorbCorey Cutler
Apr 13, 2015·International Journal of Hematology·Makoto Murata
Mar 23, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yoshihiro InamotoPaul J Martin
Oct 20, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yoshiko AtsutaUNKNOWN Japan Marrow Donor Program and Japan Cord Blood Bank Network
Jun 29, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Takehiko MoriShinichiro Okamoto
Nov 10, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hiroshi YagasakiYoshihisa Kodera
Mar 28, 2017·Annals of Hematology·Ivan Sergeevich MoiseevBoris Vladimirovich Afanasyev
Oct 10, 2019·Expert Opinion on Drug Metabolism & Toxicology·Yuan Gao, Jingjing Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.